Sun Pharmaceuticals Industries (BOM:524715) Total Equity: ₹838,797 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524715 Sun Pharmaceuticals Industries Ltd BOM:524715
92 GF Score
Price ₹1,973.50
GF Value ₹1,927.98
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Sun Pharmaceuticals Industries Total Equity?

Sun Pharmaceuticals Industries BOM:524715 +1.67% 92 Total Equity is ₹838,797 Mil as of Mar. 2026. GuruFocus rates BOM:524715 with a GF Score™ of 92/100 and a GF Value™ of ₹1,927.98 (Fairly Valued). The stock has 3 warning signs investors should review.

Sun Pharmaceuticals Industries's total equity for the quarter that ended in Mar. 2026 was ₹838,797 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Sun Pharmaceuticals Industries Total Equity Historical Data

* Premium members only.

The historical data trend for Sun Pharmaceuticals Industries's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries Total Equity Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 510,661.10 593,154.70 671,259.40 724,859.50 838,797.40

Sun Pharmaceuticals Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 724,859.50 0.00 781,265.90 0.00 838,797.40
BOM:524715
92GF Score
Sun Pharmaceuticals Industries Ltd BOM:524715
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharmaceuticals Industries Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Sun Pharmaceuticals Industries's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1087852.2-249054.8
=838,797

Sun Pharmaceuticals Industries's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1087852.2-249054.8
=838,797

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹838,797 Mil mean?
Sun Pharmaceuticals Industries (BOM:524715) has a Total Equity of ₹838,797 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Sun Pharmaceuticals Industries and its competitors.
Is Sun Pharmaceuticals Industries' Total Equity too high?
Sun Pharmaceuticals Industries' current Total Equity is ₹838,797 Mil. Overall, Sun Pharmaceuticals Industries has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharmaceuticals Industries' Total Equity compare to ZTS and UTHR?
Sun Pharmaceuticals Industries' Total Equity of ₹838,797 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Sun Pharmaceuticals Industries and its competitors. Sun Pharmaceuticals Industries's current Total Equity is ₹838,797 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharmaceuticals Industries stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries (BOM:524715) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,927.98, compared to a current price of ₹1,973.50 — trading 2.4% above its estimated fair value. The current Total Equity is ₹838,797 Mil. Sun Pharmaceuticals Industries' overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Sun Pharmaceuticals Industries (BOM:524715), the current Total Equity is ₹838,797 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharmaceuticals Industries (BOM:524715) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be overvalued. The current stock price of ₹1,973.50 is trading 2.4% above its estimated GF Value™ of ₹1,927.98. GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.

Key valuation signals for BOM:524715:

  • Total Equity: ₹838,797 Mil
  • GF Value™: ₹1,927.98 vs. price of ₹1,973.50 (2.4% above fair value)
  • GF Score™: 92/100 with 3 warning signs

No single metric tells the full story. See the BOM:524715 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharmaceuticals Industries Business Description

Other Exchanges SUNPHARMA:India
Address Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
92GF Score

Get the complete analysis for BOM:524715

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,973.50
Price
₹1,927.98
GF Value